Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-10
1995-03-14
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514414, 514369, 548483, 548484, 548485, 548490, 548491, 548181, 548182, 548183, 548468, 544 62, 544255, 544144, 544373, 5442282, 5442352, 546201, 546273, 540597, A61K 3140, C07D20910, C07D41306, C07D41706
Patent
active
053978013
ABSTRACT:
The invention relates to N-sulfonyl derivatives of formulae (I) and (I)' ##STR1## to their preparation, and to pharmaceutical compositions in which they are present. The compounds of formulae (I) and (I)' have an affinity for the vasopressin and ocytocin receptors.
REFERENCES:
patent: 3838167 (1974-09-01), Jones
patent: 4479963 (1984-10-01), Gruenfeld
CA 116:214341z Preparation . . . Ligands. Wagnon et al., p. 728, 1992.
CA 119:139091z Preparation . . . Antagonists. Wagnon et al., p. 864, 1993.
De Cointet Paul
Nisato Dino
Plouzane Claude
Serradeil-Legal Claudine
Tonnerre Bernard
Lee Mary C.
McKane Joseph K.
Sanofi
LandOfFree
N-sulfonylindoline derivatives, their preparation and the pharma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-sulfonylindoline derivatives, their preparation and the pharma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-sulfonylindoline derivatives, their preparation and the pharma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713973